Viewing Study NCT06837792


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-26 @ 8:46 PM
Study NCT ID: NCT06837792
Status: RECRUITING
Last Update Posted: 2025-04-29
First Post: 2024-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module